Increasing evidence has suggested that FOXO1 is a key downstream effector of PTEN [10] and in an array of human cancers which include prostate cancer [11–13], gastric cancer [14], and lung cancer [15], and it acts as the tumor suppressor. Here, FOXO1 is linked to prostate cancer.